Figure 3.

Domains beyond performance status (i.e., Karnofsky performance status) used in the past 12 months to assess patients age 60 years and older being considered for allogeneic hematopoietic cell transplant (alloHCT) (n=130)

*“Other” responses included: “AMPAC [Activity measure for post-acute care] Activity Score”; Activity measure for post-acute care]; “Geriatric assessment”; “PAM Score pretransplant assessment of mortality per [transplant center]”; “Physical therapy assessment”; “social work assessment”; “clinical trial for geriatric population assessment”; “full formal Geriatric assessment”; “our center is just beginning to screen alloHCT candidates that are 60 years of age or older”; “[The] whole patient and his/her support system”

CIRS-G: Cumulative Illness Rating Scale-Geriatric

HCT-CI: Hematopoietic Cell Transplantation-specific Comorbidity Index